Press Releases Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Market Closed - Japan Exchange Other stock markets 07:00:00 01/05/2024 BST			5-day change	1st Jan Change
6,561 ^JPY	-2.68%		+3.49%	+24.05%

04-30	Otsuka Holdings' Attributable Profit Jumps 26% in Q1	MT
04-29	Otsuka Holdings 2.32 Billion Yen Worth of Shares As Stock Compensation	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Otsuka Group Selected for CDP Climate Change a List for a Second Consecutive Year	02-08	AQ
Otsuka Holdings Co., Ltd. - Donations to Support Relief Efforts Following the Noto Peninsula Earthquake	01-10	AQ
Recor Medical Announces U.S. Launch and First Commercial Cases of Paradise Ultrasound Renal Denervation Therapy	11-10	BU
Recor Medical and Otsuka Medical Devices Announce First FDA-Approved Renal Denervation System for the Treatment of Hypertension	11-08	BU
Recor Medical Announces Positive Results from Six-Month Pooled Analysis of Data from the RADIANCE Global Clinical Trial Program at TCT 2023	26/10/23	BU
Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension	23/08/23	BU
Otsuka : Consolidated Financial Statements for the fiscal year ended December 31, 2022	27/04/23	PU
Otsuka Group Selected for CDP Climate Change A List	14/12/22	AQ
Otsuka Medical Devices and ReCor Medical Announce Submission of Application for Pre-Market Approval of the Paradise Ultrasound Renal Denervation System to the U.S. Food and Drug Administration	30/11/22	AQ
ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022	06/11/22	BU
Otsuka Medical Devices Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting	20/09/22	AQ
ReCor Medical Announces Results of RADIANCE II Pivotal Trial at TCT 2022 Annual Meeting	18/09/22	BU
ReCor Medical to Present RADIANCE II US Pivotal Trial Data in Late-Breaking Presentation at TCT Conference	14/09/22	BU
Otsuka : Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending December 31, 2022	29/07/22	PU
Otsuka : Notice Regarding Revisions of Consolidated Results Forecast for the first half of FY2022	26/07/22	PU
Otsuka : Medical Devices Announces Primary Endpoint Met in the RADIANCE II US Pivotal Trial of the Paradise System for the Treatment of Hypertension	26/07/22	PU
Otsuka : and Lundbeck announce positive results showing reduced agitation in patients with Alzheimer’s dementia treated with brexpiprazole	27/06/22	PU
Otsuka : Notice Concerning Completion of Payment for Disposal of Treasury Shares as Restricted Stock Compensation	28/04/22	PU
Otsuka : Consolidated Financial Statements for the fiscal year ended December 31, 2021	21/04/22	PU
Otsuka Group Joins RE100 International Initiative - Comitted to 100% Renewable Energy	21/04/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Otsuka Holdings Co., Ltd.

Equities

4578

JP3188220002

Press Releases

Filters